These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 38152078)

  • 1. Advances in the Study of MG53 in Cardiovascular Disease.
    Liu SM; Zhao Q; Li WJ; Zhao JQ
    Int J Gen Med; 2023; 16():6073-6082. PubMed ID: 38152078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MG53 preserves mitochondrial integrity of cardiomyocytes during ischemia reperfusion-induced oxidative stress.
    Gumpper-Fedus K; Park KH; Ma H; Zhou X; Bian Z; Krishnamurthy K; Sermersheim M; Zhou J; Tan T; Li L; Liu J; Lin PH; Zhu H; Ma J
    Redox Biol; 2022 Aug; 54():102357. PubMed ID: 35679798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MG53 E3 Ligase-Dead Mutant Protects Diabetic Hearts From Acute Ischemic/Reperfusion Injury and Ameliorates Diet-Induced Cardiometabolic Damage.
    Feng H; Shen H; Robeson MJ; Wu YH; Wu HK; Chen GJ; Zhang S; Xie P; Jin L; He Y; Wang Y; Lv F; Hu X; Zhang Y; Xiao RP
    Diabetes; 2022 Feb; 71(2):298-314. PubMed ID: 34844991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MG53/TRIM72: multi-organ repair protein and beyond.
    Wang YF; An ZY; Li JW; Dong ZK; Jin WL
    Front Physiol; 2024; 15():1377025. PubMed ID: 38681139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Pivotal Role of Mitsugumin 53 in Cardiovascular Diseases.
    Jiang W; Liu M; Gu C; Ma H
    Cardiovasc Toxicol; 2021 Jan; 21(1):2-11. PubMed ID: 33006052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac effects and clinical applications of MG53.
    Zhong W; Benissan-Messan DZ; Ma J; Cai C; Lee PHU
    Cell Biosci; 2021 Jun; 11(1):115. PubMed ID: 34183055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MG53's non-physiologic interaction with insulin receptor: lack of effect on insulin-stimulated Akt phosphorylation in muscle, heart and liver tissues.
    Lee KE; Nishi M; Kim J; Murayama T; Dawson Z; Wang X; Zhou X; Tan T; Cai C; Takeshima H; Park KH
    Front Endocrinol (Lausanne); 2024; 15():1425426. PubMed ID: 39355613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of MG53 in human heart precludes utility as a biomarker of myocardial injury or endogenous cardioprotective factor.
    Lemckert FA; Bournazos A; Eckert DM; Kenzler M; Hawkes JM; Butler TL; Ceely B; North KN; Winlaw DS; Egan JR; Cooper ST
    Cardiovasc Res; 2016 May; 110(2):178-87. PubMed ID: 26790476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MG53: A new protagonist in the precise treatment of cardiomyopathies.
    Zhao Q; Zhang Q; Zhao X; Tian Z; Sun M; He L
    Biochem Pharmacol; 2024 Apr; 222():116057. PubMed ID: 38367817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MG53, A Tissue Repair Protein with Broad Applications in Regenerative Medicine.
    Li Z; Wang L; Yue H; Whitson BA; Haggard E; Xu X; Ma J
    Cells; 2021 Jan; 10(1):. PubMed ID: 33440658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MG53 Mitigates Nitrogen Mustard-Induced Skin Injury.
    Li H; Li Z; Li X; Cai C; Zhao SL; Merritt RE; Zhou X; Tan T; Bergdall V; Ma J
    Cells; 2023 Jul; 12(14):. PubMed ID: 37508578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MG53 is a double-edged sword for human diseases.
    Zhang Y; Wu HK; Lv FX; Xiao RP
    Sheng Li Xue Bao; 2016 Aug; 68(4):505-16. PubMed ID: 27546510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac Ischemic Preconditioning Promotes MG53 Secretion Through H
    Shan D; Guo S; Wu HK; Lv F; Jin L; Zhang M; Xie P; Wang Y; Song Y; Wu F; Lan F; Hu X; Cao CM; Zhang Y; Xiao RP
    Circulation; 2020 Sep; 142(11):1077-1091. PubMed ID: 32677469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of metabolic syndrome on mitsugumin 53 expression and function.
    Ma H; Liu J; Bian Z; Cui Y; Zhou X; Zhou X; Zhang B; Adesanya TM; Yi F; Park KH; Tan T; Chen Z; Zhu H
    PLoS One; 2015; 10(5):e0124128. PubMed ID: 25950605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MG53 suppresses tumor growth via transcriptional inhibition of KIF11 in pancreatic cancer.
    Wang XL; He X; Gao T; Zhou X; Cruz-Monserrate Z; Tsung A; Ma J; Cai C
    Transl Oncol; 2024 Dec; 50():102118. PubMed ID: 39265509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MG53's new identity.
    Levy JR; Campbell KP; Glass DJ
    Skelet Muscle; 2013 Nov; 3(1):25. PubMed ID: 24175977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of MG53 induces diabetic cardiomyopathy through transcriptional activation of peroxisome proliferation-activated receptor α.
    Liu F; Song R; Feng Y; Guo J; Chen Y; Zhang Y; Chen T; Wang Y; Huang Y; Li CY; Cao C; Zhang Y; Hu X; Xiao RP
    Circulation; 2015 Mar; 131(9):795-804. PubMed ID: 25637627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective role of MG53 against ischemia/reperfusion injury on multiple organs: A narrative review.
    Xu B; Wang C; Chen H; Zhang L; Gong L; Zhong L; Yang J
    Front Physiol; 2022; 13():1018971. PubMed ID: 36479346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioprotection of recombinant human MG53 protein in a porcine model of ischemia and reperfusion injury.
    Liu J; Zhu H; Zheng Y; Xu Z; Li L; Tan T; Park KH; Hou J; Zhang C; Li D; Li R; Liu Z; Weisleder N; Zhu D; Lin P; Ma J
    J Mol Cell Cardiol; 2015 Mar; 80():10-19. PubMed ID: 25533937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardioprotection of ischemia/reperfusion injury by cholesterol-dependent MG53-mediated membrane repair.
    Wang X; Xie W; Zhang Y; Lin P; Han L; Han P; Wang Y; Chen Z; Ji G; Zheng M; Weisleder N; Xiao RP; Takeshima H; Ma J; Cheng H
    Circ Res; 2010 Jul; 107(1):76-83. PubMed ID: 20466981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.